Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals
iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.;
Advertisement
New Delhi: The central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as a booster dose for those above 18 years of age.
The Union Health Ministry said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
The vaccine will be available on the CoWIN app starting today.
Prime Minister Narendra Modi had chaired a high-level meeting yesterday to review the status and preparedness of public health response to COVID-19 and emphasised the need for strengthened surveillance with a focus on genome sequencing and increased testing.
This high-level review meeting comes against the backdrop of a spike in COVID-19 cases in some countries, according to the Prime Minister's Office.
PM Modi assessed the COVID-19 situation in the country, the preparedness of health infrastructure and logistics, and the status of the vaccination campaign in the country. He also evaluated the emergence of new Covid-19 variants and their public health implications.
Over the last two days, Chief Ministers of many states around the country have conducted high-level meetings with Senior Officials regarding the preparedness for Covid19 in their states.
The sub-variant of the Omicron variant BF.7, that is driving the new surge in Covid cases in China, Japan, South Korea, France, and the United States, has been detected in India also. A total of four cases have been reported in four states in India -- the first one in July and the latest in November. Overall cases in India continue to be relatively meagre, at fewer than 200 daily for several days now.
As per sources, there are currently 10 different variants of Covid-19 in the country, with the latest being BF.7.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.